Our Biotechnology & Biologics group includes Ph.D.s and other attorneys with formal scientific training who have personally contributed original research to a variety of fields, including immunology, molecular biology, cell biology, biochemistry and plant sciences.
Advanced degrees, scientific research experience and practical business experience in the biotechnology industry enable these lawyers to understand and appreciate technical innovations quickly, and to focus efficiently on our clients’ legal needs.
We have extensive experience in securing and advising on patent rights in all aspects of the biotechnology spectrum, including bioinformatics, genomics, genome editing, DNA sequencing, antisense and recombinant DNA technology, monoclonal antibody applications, vaccines, transgenic plants and animals, diagnostic assays and medical devices. Moreover, we are also skilled at the complex issues which arise in defending and asserting biotechnology patents, having handled several major litigation matters in this field.
Clients for whom we have worked on biotechnology patent matters include Asgrow Seed, Chiron, Kyowa Hakko Kogyo, Merck, Monsanto, Novartis, Regeneron, Seminis and Takeda.
A lawyer cannot understand your legal issue without also understanding your business.
At Fitzpatrick, we are not in the business of providing legal services for our clients’ own sake, but rather to advance their business goals. Assisting in the achievement of those goals demands a thorough understanding of our clients’ technology (or other intellectual property), as well as business trends and practices in the industries within which they operate.
Our attorneys bring that knowledge in the form of education, industry research, and frequently long years of industry experience. A great many of Fitzpatrick’s attorneys have scientific degrees relevant to their clients’ industries — others bring extensive work experience in their clients’ fields. Our industry group leaders include Lock See Yu-Jahnes, Ph.D., who researched thin-film electronic devices before heading the Semiconductor Technologies group; and Robert S. Schwartz, Ph.D., who investigated biomedical research before co-leading our Biotechnology group.
In all of our industry areas, our attorneys bring similar levels of industry-specific learning and experience to inform their work for clients. We invite you to contact our industry group leaders for more information.